Cargando…
Real-World First-Line Treatment Patterns and Outcomes in Hormone Receptor-Positive Advanced Breast Cancer Patients: A Multicenter, Retrospective Study in China
BACKGROUND: Recent data on first-line treatment patterns administered to hormone receptor-positive (HR+) advanced breast cancer (ABC) patients in the real-world setting are limited. This study aimed to report the first-line treatment patterns and outcomes of HR+ ABC patients in China. METHODS: This...
Autores principales: | Chen, Zhanhong, Ouyang, Quchang, Wang, Yongsheng, Wang, Junsheng, Wang, Haixue, Wu, Xiaohong, Zhang, Peili, Huang, Jian, Zheng, Yabing, Cao, Wenming, Shao, Xiying, Xie, Ning, Tian, Can, Liang, Hao, Wang, Cailing, Zhang, Ying, Ren, Dianquan, Wang, Xiaojia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928103/ https://www.ncbi.nlm.nih.gov/pubmed/35311126 http://dx.doi.org/10.3389/fonc.2022.829693 |
Ejemplares similares
-
Exploring the concepts and practices of advanced breast cancer treatment: a narrative review
por: Wang, Xiaojia, et al.
Publicado: (2021) -
Ki67 and progesterone receptor status predicts sensitivity to palbociclib: a real-world study
por: Shao, Xiying, et al.
Publicado: (2021) -
The CYP19 RS4646 Polymorphism IS Related to the Prognosis of Stage I–II and Operable Stage III Breast Cancer
por: Shao, Xiying, et al.
Publicado: (2015) -
Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling
por: Chen, Zhanhong, et al.
Publicado: (2019) -
Long-term tolerance and cardiac function in breast cancer patients receiving trastuzumab therapy
por: Huang, Ping, et al.
Publicado: (2016)